You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endometrial Carcinoma

Showing 1 - 25 of 9,710
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

Recruiting
  • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
  • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 22, 2023

Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

Not yet recruiting
  • Endometrial Carcinoma
  • Tumor Molecular Features Screening Model
  • open surgery
  • laparoscopic surgery
  • (no location specified)
Jun 7, 2023

Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)

Not yet recruiting
  • Endometrial Carcinoma
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma Stage I
  • Medroxyprogesterone acetate + Atorvastatin
  • Peking, Beijing, China
    Wang Jianliu
Dec 29, 2022

Endometrial Cancer Trial in Zagazig (Tissue Biopsy)

Completed
  • Endometrial Cancer
  • Tissue Biopsy
  • Zagazig, Ash Sharqia Governorate, Egypt
    Zagazig university
Nov 27, 2023

Endometrial Carcinoma Cellular Diagnosis Trial (1.hysterectomy with bilateral oophorectomy and pelvic lymphonodectomy. 2

Completed
  • Endometrial Carcinoma Cellular Diagnosis
  • 1.hysterectomy with bilateral oophorectomy and pelvic lymphonodectomy. 2 explorative curettage
  • (no location specified)
Jul 16, 2023

Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

Not yet recruiting
  • Endometrial Cancer and Endometrial Hyperplasia
  • microscopic pathological evaluation
  • Sohag, Egypt
    Sohag University Hospital
Nov 8, 2022

Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma Trial in Miami (Lenvatinib, Pembrolizumab, Hypofractionated

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Unresectable Endometrial Carcinoma
  • Miami, Florida
    University of Miami
Jan 10, 2023

Unusual Infiltrative Patterns of Malignant Cells in Endometrial

Not yet recruiting
  • Endometrial Cancer
    • (no location specified)
    Mar 11, 2023

    Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

    Recruiting
    • Endometrial Adenocarcinoma
    • Comparison of adjuvant therapies
    • Helsinki, Finland
      Helsinki University Hospital
    Dec 8, 2022

    Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

    Not yet recruiting
    • Colorectal Carcinoma (CRC)
    • Endometrial Carcinoma (EC)
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Nov 8, 2023

    Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)

    Recruiting
    • Metastatic Cancer
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

    Recruiting
    • Recurrent Endometrial Adenocarcinoma
    • +8 more
    • Ipilimumab
    • Nivolumab
    • Iowa City, Iowa
    • +9 more
    Jan 27, 2023

    Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

    Not yet recruiting
    • Endometrial Cancer
    • +5 more
    • Oklahoma City, Oklahoma
      University Oklahoma Stephenson Cancer Center
    Aug 16, 2023

    Endometrial Carcinoma, Obesity, EIN Trial in Boston (CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral)

    Recruiting
    • Endometrial Carcinoma
    • +4 more
    • CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
    • Boston, Massachusetts
    • +1 more
    Aug 2, 2022

    Prediction of Lymph Node Involvement in Endometrial Carcinoma

    Completed
    • Endometrial Cancer
    • hysterectomy
    • Assiut, Cairo, Egypt
      Ahmed Abbas
    Aug 24, 2022

    Endometrial Cancer, Endometrial Carcinosarcoma, Endometrial Carcinoma Trial in United States (Durvalumab, Tremelimumab)

    Completed
    • Endometrial Cancer
    • +4 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

    Not yet recruiting
    • Metastatic Endometrial Carcinoma
    • +7 more
    • Biopsy
    • +5 more
    • (no location specified)
    Jan 18, 2023

    Targeting Inflammation for Endometrial Cancer Prevention

    Recruiting
    • Endometrial Carcinoma
    • Biospecimen Collection
    • Questionnaire Administration
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jan 5, 2023

    Developing a MRI-based Deep Learning Model to Predict MMR Status

    Not yet recruiting
    • Endometrial Cancer
    • randomly divided
    • (no location specified)
    Mar 13, 2023

    Endometrial Carcinoma Trial (Lerociclib, Letrozole 2.5mg, Placebo)

    Not yet recruiting
    • Endometrial Carcinoma
    • (no location specified)
    Jan 26, 2023

    Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated

    Recruiting
    • Endometrial Cancer
    • +4 more
    • Intensity-modulated radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 10, 2023

    Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

    Not yet recruiting
    • Endometrial Carcinoma Stage I
    • Atypical Endometrial Hyperplasia
    • No intervention
    • (no location specified)
    Dec 3, 2022

    Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

    Recruiting
    • Recurrent Endometrial Carcinoma
    • +12 more
    • Houston, Texas
    • +1 more
    Sep 22, 2022

    Endometrial Carcinoma Trial in New Haven (Sacituzumab Govitecan)

    Recruiting
    • Endometrial Carcinoma
    • Sacituzumab Govitecan
    • New Haven, Connecticut
      Smilow Cancer Hospital at Yale New Haven
    Apr 4, 2022